Administration, Cutaneous
"Administration, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
Concept/Terms
Administration, Cutaneous- Administration, Cutaneous
- Administration, Dermal
- Administrations, Dermal
- Dermal Administrations
- Dermal Administration
- Cutaneous Administration
- Administrations, Cutaneous
- Cutaneous Administrations
- Skin Administration, Drug
- Drug Skin Administrations
- Skin Administrations, Drug
- Drug Administration, Cutaneous
- Administration, Cutaneous Drug
- Administrations, Cutaneous Drug
- Cutaneous Drug Administrations
- Drug Administrations, Cutaneous
- Cutaneous Drug Administration
- Dermal Drug Administration
- Administration, Dermal Drug
- Administrations, Dermal Drug
- Dermal Drug Administrations
- Drug Administrations, Dermal
- Drug Administration, Dermal
- Skin Drug Administration
- Skin Drug Administrations
- Cutaneous Administration, Drug
- Cutaneous Administrations, Drug
Administration, Transcutaneous- Administration, Transcutaneous
- Administrations, Transcutaneous
- Transcutaneous Administrations
- Administration, Transdermal
- Administrations, Transdermal
- Transdermal Administrations
- Transdermal Administration
- Transcutaneous Administration
Percutaneous Administration- Percutaneous Administration
- Administration, Percutaneous
- Administrations, Percutaneous
- Percutaneous Administrations
Below are MeSH descriptors whose meaning is more general than "Administration, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Cutaneous".
This graph shows the total number of publications written about "Administration, Cutaneous" by people in Harvard Catalyst Profiles by year, and whether "Administration, Cutaneous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 2 | 13 | 15 |
1996 | 2 | 13 | 15 |
1997 | 1 | 6 | 7 |
1998 | 0 | 7 | 7 |
1999 | 0 | 6 | 6 |
2000 | 1 | 5 | 6 |
2001 | 0 | 12 | 12 |
2002 | 0 | 13 | 13 |
2003 | 0 | 17 | 17 |
2004 | 1 | 6 | 7 |
2005 | 1 | 9 | 10 |
2006 | 0 | 17 | 17 |
2007 | 1 | 15 | 16 |
2008 | 0 | 19 | 19 |
2009 | 0 | 17 | 17 |
2010 | 0 | 19 | 19 |
2011 | 1 | 15 | 16 |
2012 | 0 | 22 | 22 |
2013 | 0 | 17 | 17 |
2014 | 1 | 17 | 18 |
2015 | 0 | 19 | 19 |
2016 | 1 | 12 | 13 |
2017 | 0 | 18 | 18 |
2018 | 2 | 16 | 18 |
2019 | 1 | 9 | 10 |
2020 | 0 | 15 | 15 |
2021 | 0 | 16 | 16 |
2022 | 0 | 9 | 9 |
2023 | 0 | 10 | 10 |
2024 | 0 | 2 | 2 |
Below are the most recent publications written about "Administration, Cutaneous" by people in Profiles.
-
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment. JAMA Dermatol. 2024 Feb 01; 160(2):237-238.
-
Novel 40?µm spot size 3050/3200?nm DFG laser versus CO2 laser for laser-assisted drug delivery. Lasers Surg Med. 2024 Feb; 56(2):186-196.
-
A Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma. J Drugs Dermatol. 2023 Dec 01; 22(12):1223-1224.
-
Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial. Menopause. 2024 Jan 01; 31(1):10-17.
-
Effects of Superficial Scratching and Engineered Nanomaterials on Skin Gene Profiles and Microbiota in SKH-1 Mice. Int J Mol Sci. 2023 Oct 26; 24(21).
-
Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study. J Am Acad Dermatol. 2024 Jan; 90(1):189-192.
-
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation. Clin Exp Dermatol. 2023 08 25; 48(9):1058-1060.
-
Warts in pediatric oncology patients: A single-institution retrospective study. Pediatr Dermatol. 2023 Sep-Oct; 40(5):816-819.
-
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.
-
Acoustic metamaterials-driven transdermal drug delivery for rapid and on-demand management of acute disease. Nat Commun. 2023 02 16; 14(1):869.